Inactive Instrument

Company AIT Therapeutics Inc Other OTC

Equities

US50027L1070

Medical Equipment, Supplies & Distribution

End-of-day quote Other OTC
- USD - Intraday chart for AIT Therapeutics Inc

Business Summary

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received United States Food and Drug Administration (FDA) approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. It is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19), and nontuberculous mycobacteria (NTM) among others. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder (ASD) and other neurological disorders. Its approved product and active pipeline of product candidates include LungFit PH, LungFit PRO and LungFit GO.

Sales per Business

USD in Million2023Weight2024Weight Delta
Beyond Air
100.0 %
0 nan % 1 100.0 % -

Sales per region

USD in Million2023Weight2024Weight Delta
United States
100.0 %
0 nan % 1 100.0 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 53 17-01-12
Director of Finance/CFO 53 21-08-31
President 50 17-01-12
Chief Tech/Sci/R&D Officer - 21-11-30
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 23-03-26
Chief Operating Officer 70 20-04-30
Investor Relations Contact - 22-09-30
Sales & Marketing - 21-05-19
Corporate Officer/Principal - 21-05-02

Members of the board

Members of the board TitleAgeSince
Director/Board Member 58 15-07-31
Director/Board Member 62 18-08-12
Director/Board Member 57 17-08-09
Chief Executive Officer 53 17-01-12
President 50 17-01-12
Director/Board Member 65 19-02-12
Director/Board Member 51 18-01-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 45,900,821 37,322,801 ( 81.31 %) 0 81.31 %

Shareholders

NameEquities%Valuation
AIGH Capital Management LLC
8.092 %
3,714,458 8.092 % 5 M $
3,221,434 7.018 % 4 M $
2,976,864 6.485 % 4 M $
BlackRock Advisors LLC
3.785 %
1,737,361 3.785 % 2 M $
1,701,099 3.706 % 2 M $
Tontine Associates LLC
3.183 %
1,461,071 3.183 % 2 M $
Vanguard Fiduciary Trust Co.
3.049 %
1,399,298 3.049 % 2 M $
Kingdon Capital Management LLC
2.959 %
1,358,164 2.959 % 2 M $
Adar1 Capital Management LLC
2.625 %
1,204,820 2.625 % 2 M $
RTW Investments LP
2.625 %
1,204,820 2.625 % 2 M $

Company contact information

Beyond Air, Inc.

900 Stewart Avenue Suite 301

11530, Garden City

+516 665 8200

http://www.beyondair.net
address AIT Therapeutics Inc
  1. Stock Market
  2. Equities
  3. XAIR Stock
  4. Stock
  5. Company AIT Therapeutics Inc